Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Basic Pharma is an independent Dutch pharmaceutical company specializing in the development, licensing, manufacturing, and commercialization of both generic pharmaceutical products and biopharmaceuticals. It operates as a CDMO with expertise in co-developing formulations, producing investigational medicinal products for clinical trials, providing quality control services, and supporting both established companies and start-ups. The company has recently focused on innovative biologics such as recombinant human serum albumin (rHSA) through partnerships like ARTES Biosciences. Its main revenue comes from niche generics sold under private labels by pharmacies or drugstores. The company maintains full compliance with GMP standards using advanced electronic QMS systems to ensure regulatory compliance across its operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Basic Pharma.